Head and neck cancer: Buparlisib is an effective second-line treatment
- PMID: 28195237
- DOI: 10.1038/nrclinonc.2017.22
Head and neck cancer: Buparlisib is an effective second-line treatment
References
-
- Lancet Oncol. 2017 Mar;18(3):323-335 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources